Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Treatment Strategies in Pancreatic Cancer.

Pancreas - 1 Jul 2021

Trunk Andrew, Miotke Laura, Nevala-Plagemann Christopher, Verdaguer Helena, Macarulla Teresa, Garrido-Laguna Ignacio

Abstract excerpt

ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) is one of the main causes of cancer death in well-developed countries. Therapeutic advances in PDAC to date have been modest. Recent progress to understand the molecular landscape of the disease has opened new treatment opportunities for a small subset of patients, frequently those with KRAS wild-type disease. Novel treatment strategies in PDAC include, among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Immunotherapy

Share to Immunotherapy, Adoptive

Share to Molecular Targeted Therapy

Share to Outcome Assessment, Health Care

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 34398070
DOI: 10.1097/MPA.0000000000001845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Treatment Strategies in Pancreatic Cancer.PMID 34398070Read ↗

New therapeutic targets in pancreatic cancer.Semantic proximity Read ↗

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read ↗

Targeted Therapies in Pancreatic Cancer: A New Era of Precision MedicineSemantic proximity Read ↗

Current advances in immunotherapy for KRAS-Mutant pancreatic cancer.Semantic proximity Read ↗

Treating Pancreatic Ductal Adenocarcinoma: The Targeted Revolution is Here.Semantic proximity Read ↗

Advances in the Treatment of Pancreatic CancerSemantic proximity Read ↗

Recent advances in the treatment of pancreatic cancerSemantic proximity Read ↗

Current Treatment Methods in Pancreatic Cancer and the Need for ImprovementSemantic proximity Read ↗

Emerging drugs in the treatment of pancreatic cancer.Semantic proximity Read ↗

Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)Semantic proximity Read ↗

Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.Semantic proximity Read ↗

Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.